文献速递头颈技术与安全CT

基于增强CT的深度学习模型预测口咽鳞状细胞癌总生存期:一项前瞻性多中心研究

Deep learning model using contrast-enhanced CT for predicting overall survival in oropharyngeal squamous cell carcinoma: a prospective multicenter study.
PubMed 文献 · Eur Radiol · 2025-11-06

该研究基于增强CT开发并验证了深度学习模型(DLCS),用于预测口咽鳞状细胞癌患者的总生存期。回顾性纳入三个中心269例患者(训练集144例、内部验证56例、外部验证69例),另用前瞻性队列50例进行HPV亚组分析。DLCS在内部验证集C指数为0.856、外部验证集为0.783,能有效进行风险分层并在HPV亚组中保持预测一致性。

要点

  • DLCS在内部验证集C指数0.856、外部验证集C指数0.783。
  • DLCS可提供准确的1年、3年和5年总生存期预测及稳健校准。
  • DLCS能将患者分为高、低风险组,并在HPV亚组中保持预测一致性。

核心结论

  • 基于增强CT的深度学习-临床特征联合模型(DLCS)在口咽鳞状细胞癌中提供可靠的总生存期预测和风险分层,支持个体化临床决策和精准肿瘤学。

研究设计与样本

  • 研究为回顾性多中心队列(三个中心269例,训练集144例、内部验证56例、外部验证69例)加前瞻性队列(50例)用于HPV亚组分析;基于增强CT图像,使用PyRadiomics提取影像组学特征,开发基于Swin Transformer V2的深度学习模型,通过多因素Cox回归筛选临床和语义CT特征,构建联合模型;采用C指数、时间依赖ROC、校准评估和决策曲线分析评估性能。

诊断标准与关键数值

  • DLCS在内部验证集C指数为0.856,外部验证集C指数为0.783;提供1年、3年和5年总生存期预测,具有稳健校准和临床获益;基于X-tile确定的最佳截断值进行Kaplan-Meier分析,有效分层高、低风险组,并在HPV亚组中保持预测一致性。

临床应用与阅片要点

  • DLCS可作为基于增强CT的无创预后工具,用于口咽鳞状细胞癌患者的总生存期风险分层,区分高、低风险患者,支持个体化治疗策略和临床决策优化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Accurate risk stratification for overall survival (OS) in patients with oropharyngeal squamous cell carcinoma (OPSCC) is critical for guiding personalized treatment and surveillance. A deep learning (DL) model was developed and validated to estimate OS in OPSCC patients based on contrast-enhanced computed tomography (CECT).

MATERIALS AND METHODS: A total of 269 patients from three centers were retrospectively enrolled and divided into training (n = 144), internal validation (n = 56), and external validation (n = 69) cohorts. An additional prospective cohort (n = 50) was used for HPV-based subgroup analysis. Clinical and semantic CT features were selected via multivariate Cox regression. Radiomic features were extracted using PyRadiomics. A Swin Transformer V2-based DL model was developed to estimate OS risk. SHAP values and Grad-CAM were used to assess model interpretability. Combined models were constructed by integrating clinical factors, handcrafted radiomics features, and DL score values. Predictive accuracy and clinical utility of the model were evaluated through C-index, time-dependent ROC analysis, calibration assessment, and decision curve analysis. Kaplan-Meier analysis was performed based on the optimal cutoff identified by the X-tile.

RESULTS: Deep learning-clinical signature (DLCS) achieved the best performance, with C-indices of 0.856 (internal) and 0.783 (external). It provided accurate 1-, 3-, and 5-year OS predictions, robust calibration, and clinical benefit. DLCS effectively stratified patients into high- and low-risk groups and maintained predictive consistency across HPV subgroups.

CONCLUSIONS: The CECT-based DLCS offers reliable OS prediction and risk stratification in OPSCC, supporting individualized clinical decision-making and precision oncology.

KEY POINTS: Question Prognostic prediction in OPSCC is crucial for personalized treatment, yet existing clinical tools lack accuracy and non-invasiveness. Findings The DLCS integrates imaging and clinical data to achieve precise OS prediction and robust risk stratification in OPSCC. Clinical relevance The DLCS offers a novel, non-invasive, and accurate prognostic tool for OPSCC, enabling differentiation between high- and low-risk patients. This supports personalized treatment strategies and optimizes clinical decision-making.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Jiang T, Song C, Wang T, et al. Deep learning model using contrast-enhanced CT for predicting overall survival in oropharyngeal squamous cell carcinoma: a prospective multicenter study. Eur Radiol. 2025. PMID: 41196362. doi:10.1007/s00330-025-12120-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。